The present invention is directed to a fluorescent dye comprising a benzothiazolium moiety and a pyrimidinium moiety connected by a mono-methine bridge, characterized in that (i) the 2-position of the pyrimidine carries a substituent which starts with a C-atom and (ii) the 5- and 6-positions of the pyrimidine ring are an integral part of a further aromatic ring structure.
Disclosed is a fluorescent dye comprising a benzothiazolium moiety and a pyrimidinium moiety connected by a mono-methine bridge, characterized in that (i) the 2-position of the pyrimidine carries a substituent which starts with a C-atom and (ii) the 5- and 6- positions of the pyrimidine ring are an integral part of a further aromatic ring structure as exemplified by the following:
Mitochondrial health parameters as clinical predictors of Parkinson's disease
申请人:University of Pittsburgh - Of the Commonwealth System of Higher Education
公开号:US11001890B2
公开(公告)日:2021-05-11
Methods are disclosed for detecting peripheral mitochondrial DNA damage and dysfunction. Methods are also disclosed that utilize blood samples to detect a neurodegenerative disease, such as Parkinson's disease, and determine the efficacy of therapy.
本研究公开了检测外周线粒体 DNA 损伤和功能障碍的方法。还公开了利用血液样本检测神经退行性疾病(如帕金森病)并确定疗效的方法。
NEW DS DNA BINDING FLUORESCENT DYES
申请人:Roche Diagnostics GmbH
公开号:EP2087043A1
公开(公告)日:2009-08-12
MITOCHONDRIAL HEALTH PARAMETERS AS CLINICAL PREDICTORS OF PARKINSON'S DISEASE
申请人:University of Pittsburgh - Of the Commonwealth System of Higher Education
公开号:US20180251838A1
公开(公告)日:2018-09-06
Methods are disclosed for detecting peripheral mitochondrial DNA damage and dysfunction. Methods are also disclosed that utilize blood samples to detect a neurodegenerative disease, such as Parkinson's disease, and determine the efficacy of therapy.